Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis

International Journal of Cancer

Volumn 69, Issue 3, 1996, Pages 174-179

  Ren, Zhi Ping ^a   Pontén, Fredrik ^a   Nistér, Monica ^a   Pontén, Jan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; PRECANCER; PRIORITY JOURNAL; SKIN CANCER; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MUTATION; PAPILLOMA; PRECANCEROUS CONDITIONS; REFERENCE VALUES; SKIN; SKIN NEOPLASMS; SKIN PHYSIOLOGY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030016929     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960621)69:3<174::AID-IJC4>3.0.CO;2-X     Document Type: Article

References (23)

1. BRASH, D.E., RUDOLPH, J.A., SIMON, J.A., LIN, A., MCKENNA, G.J., BADEN, H.P., HALPERIN, A.J. and PONTÉN, J., A role for sunlight in skin cancer: UV-induced p53 mutations in squamous-cell carcinoma. Proc. nat. Acad. Sci. (Wash.), 88, 10124-10128 (1991).
2. CAMPBELL, C., QUINN, A.G., ANGUS, B., FARR, P.M. and REES, J.L., Wavelength specific patterns of p53 induction in human skin following exposure to UV irradiation. Cancer Res., 53, 2697-2699 (1993a).
3. CAMPBELL, C., QUINN, A., ANGUS, B. and REES, J., The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Brit. J. Dermatol, 129, 235-241 (1993b).
4. FEARON, E.R. and VOGELSTEIN, B., A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
5. FOULDS, L., Tumor progression. Cancer Res., 17, 355-356 (1957).
6. GOODMAN, B., p53 Database. AutoExtractor F-1.33. Gene Chrom. Cancer, 6, 1-15 (1994).
7. HALL, P.A., MCKEE, P.H., MENAGE, H.D.P., DOVER, R. and LANE, D.P., High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8, 203-207 (1993).
8. HARRIS, C.C. and HOLLSTEIN, M., Clinical implications of the p53 tumor-suppressor gene. New Engl. J. Med., 329, 1318-1327 (1993).
9. HEDRUM, A., PONTÉN, F., REN, Z., LUNDEBERG, J., PONTÉN, J. and UHLÉN, M., Sequence-based analysis of the human p53 gene based on microdissection of tumor biopsy samples. BioTechniques, 17, 118-129 (1994).
10. KERSCHMANN, R., MCCALMONT, T. and LEBOIT, P., p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch. Dermatol., 130, 181-186 (1994).
11. LANE, D.P., p53, guardian of the genome. Nature (Lond.), 358, 15-16 (1992).
12. LEVER, W.F. and SCHAUMBERG-LEVER, G., Histopathology of the skin, 7th ed., Lippincott, Philadelphia (1990).
13. LIVINGSTONE, L.R., WHITE, A., SPROUSE, J., LIVANOS, E., JACKS, T. and TLSTY, T.D., Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935 (1992).
14. LOEB, L.A., Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51, 3075-3079 (1991).
15. MCGREGOR, J.M., YU, C., DUBLIN, E. and MACDONALD, D., Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Brit. J. Dermatol., 127, 463-469 (1992).
16. MOLES, J.P., MOYRET, C., GUILLOT, B., JEANTEUR, P., GUILHOU, J.J., THEILLET, C. and BASSET-SEGUIN, N., p53 gene mutations in human epithelial skin cancers. Oncogene, 8, 583-588 (1993).
17. NAVONE, N.M., TRONOSCO, P., PISTERS, L.L., GOODROW, T.L., PALMER, J.L., NICHOLS, W.W., VON ESCHENBACH, A.C. and CONTI, C.J., p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J. nat. Cancer Inst., 85, 1657-1669 (1993).
18. NELSON, M.A., EINSPAHR, J., ALBERTS, D., BALFOUR, C., WYMER, J., WELCH, K., SALASCHE, S., BANGERT, J., GROGAN, T. and BOZZO, P., Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett., 85, 23-29 (1994).
19. PONTÉN, J., Hypotheses for the genesis of UV-induced non-melanotic human skin cancer. Folia biol. (Praha), 40, 263-279 (1994).
20. PONTÉN, F., BERNE, B., REN, Z.-P., NISTÉR, M. and PONTÉN, J., Ultraviolet light induces expression of p53 and p21 in human skin; effect of sunscreen and constitutive p21 expression in skin appendages. J. invest. Dermatol., 105, 402-406 (1995).
21. REN, Z.-P., HEDRUM, A., PONTÉN, F., NISTÉR, M., AHMADIAN, A., LUNDEBERG, J., UHLÉN, M. and PONTÉN, J., Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene, (1996). 12, 765-773.
22. YIN, Y., TAINSKY, M.A., BISCHOFF, F.Z., STRONG, L.C. and WHAL, G.M., Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948 (1992).
23. ZIEGLER, A., JONASON, A.S., LEFFEL, D.J., SIMON, J.A., SHARMA, H.W., KIMMELMAN, J., REMINGTON, L., JACKS, T. and BRASH, D.E., Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372, 773-776 (1994).